Compare MWA & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MWA | BLLN |
|---|---|---|
| Founded | 1857 | 2016 |
| Country | United States | United States |
| Employees | 3500 | N/A |
| Industry | Metal Fabrications | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.4B |
| IPO Year | 2006 | 2025 |
| Metric | MWA | BLLN |
|---|---|---|
| Price | $23.84 | $102.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $30.50 | ★ $126.71 |
| AVG Volume (30 Days) | ★ 810.9K | 550.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | 64.86 | ★ 103.40 |
| EPS | ★ 1.08 | 0.48 |
| Revenue | ★ $1,429,700,000.00 | $305,112,000.00 |
| Revenue This Year | $4.78 | $46.29 |
| Revenue Next Year | $4.27 | $30.14 |
| P/E Ratio | ★ $22.00 | $206.38 |
| Revenue Growth | 8.75 | ★ 99.97 |
| 52 Week Low | $22.74 | $61.96 |
| 52 Week High | $31.00 | $150.44 |
| Indicator | MWA | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 37.94 | 50.62 |
| Support Level | N/A | $88.85 |
| Resistance Level | $25.40 | $108.50 |
| Average True Range (ATR) | 0.48 | 4.77 |
| MACD | -0.10 | 1.70 |
| Stochastic Oscillator | 19.32 | 92.58 |
Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments: Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.